Hybridan Small Cap Feast: 09/05/2024
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
Delistings:
has left AIM.
has left AIM.
What’s baking in the oven? **
Potential**** Initial Public Offerings:
7th May: Time To ACT plc, an engineering business focused on technology for the energy transition sector, has announced its intention to seek Admission to trading on the Aquis Stock Exchange Growth Market. The Company reports it is revenue generating, profitable in FY23, with £1.9m cash in the bank at 31st March 2024. The Company's application to the AQSE Growth Market is not conditional on it raising funds. However, the Company is seeking to raise up to £1m of new money to de-risk growth and in support of its strategy of coupling organic growth and acquisition.
Reverse Takeovers:
Change of Market:
Dual Listing:
Banquet Buffet***
136.5p £41.8m (AREC.L)
The biopharmaceutical group advancing today's therapies to enable healthier lives, announced a research collaboration with Medtronic plc (NYSE: MDT) to develop a novel, high concentration, thermostable insulin for use by Medtronic's Diabetes business in a next-generation implantable pump. This new insulin has the potential to bring significant advancements in the current insulin treatment options for a small population of patients who have limited options for controlling their diabetes with traditional therapy.
0.825p £14.3m (ARV.L)
The company engaged in exploration and development of mineral properties in Australia, announces high-grade assay results from Mt Marie Prospect (100% ARV): 24AR04-07 - 4.63% Li2O; o 24AR04-14 - 4.52% Li2O; 24AR04-13 -4.28% Li2O; 24AR04-12 - 3.63% Li2O and 24AR04-04 - 3.45% Li2O and Osborne East Prospect (100% ARV): Further multiple rock chip assays >0.50% Li2O. The recent ground reconnaissance program continues to demonstrate consistency, growing the strike length and grade of its lithium prospects in the Pilbara region of Western Australia.
9.5p £71.0m (AURA.L)
The Australian-based mineral company with major uranium and polymetallic projects in Africa and Europe, provides an update on the restructuring of the Curzon Uranium Ltd. uranium offtake agreement. The restructured offtake agreement improves the NPV by US$22m to US$388m and increases the IRR by 2% to 36% compared to Front End Engineering Design (FEED) study economics delivered in March 2024. Curzon has elected to receive the US$3.5m restructuring fee in Aura shares priced at A$0.18 per share, in lieu of a cash settlement. Curzon will also take a US$3.5m placement of Aura shares at A$0.18 per share. In sum, Curzon will be issued 59,829,060 new shares in Aura and will hold approximately 8% of the issued stock in Aura.
5.65p £21.9m (BIRD.L)
The technology licensor, developer and seller of market-leading cloud native video editing platform, Blackbird, and developer of the multiplayer editor in a browser, elevate.io, announces that Dawn Airey has notified the Company of her intention to step down as a Non-Executive Director of the Company, with effect from 31 May 2024, in order to focus on her other business commitments. The Company has initiated a process to appoint a new Non-Executive Director and a further announcement will be made in due course.
300p £56.6m (CCT.L)
The UK-based company engaged in the design, development and international distribution of toys, games and giftware, announces its unaudited six-month results ended 29 February 2024 (1H FY24). Revenue was £57.6m (1H FY23: £57.9m) and profit before tax was £2.2m (1H FY23: £0.2m). Cash and cash equivalents totalled £12.9m (£10.7m cash as at 28 February 2023). On the back of the first half-year's performance, the Group anticipates profit before tax and highlighted items in respect of the full year to 31 August 2024 to exceed current market expectations.
39p £113.3m (ECK.L)
The global provider of Customer Engagement Data Security Solutions, announces a trading update for the year ended 31 March 2024 (FY24). The Board expects to report revenues of approximately £37.2m (compared to FY23 £38.8m), slightly behind market expectations, due to ongoing transition of client deployments to the cloud and the elongated sales cycles. However, Eckoh expects to report adjusted operating profit of approximately £8.3m (FY23 £7.7m), marginally ahead of market expectations. As a result of margin improvement and strong cash generation, the cash position increased to £8.3m at the end of FY24 (FY23: £5.7m), also marginally ahead of market expectations.
309.5p £122.0m (FDEV.L)
The developer and publisher of videogames based in Cambridge, UK, announces the signing of a licence with Universal Products & Experiences for a third Jurassic World game. Following the success of Jurassic World Evolution and Jurassic World Evolution 2, which released in June 2018 and November 2021 respectively, Frontier and Universal Products & Experiences have signed a licence for a third Jurassic World game which is scheduled for release in Frontier's financial year 2026, between 1 June 2025 and 31 May 2026. In February 2024, Universal Pictures and Amblin Entertainment announced an all-new Jurassic World event film currently scheduled for release on 2 July 2025.
3.15p £10.5m (LST.L)
The company operating in three divisions: controlled environment agriculture (CEA); contract electronics manufacturing (CEM) and passive fire protection (PFP), announces an exclusive distribution agreement with agricultural automation provider AgriLogiq Technical Systems (PTY) LTD for marketing and sale of the Company’s nurturGROW lights in South Africa. This agreement is for an initial period of five years.
4.85p £102.1m (MTL.L)
The gold producer in the Philippines provides an update on its mezzanine debt facilities. Further to the announcement on 27 March 2024, Runruno Holdings Limited and D&A Holdings Limited have written to the Company disputing the Company's position that a 7% (as opposed to 15%) interest rate should apply under the Company's mezzanine facilities since 3 November 2022. MTL (Luxembourg) S.à r.l. (Nick Candy's investment vehicle, holding 70.7% of the mezzanine debt) is also seeking to receive this interest rate on its own loans to the Company. Hence, the Company will make pro-rated settlement payments of US$2.2m to MTL Lux and US$0.91m to the RHL Group, being approximately 50% of the amount that would be due to MTL Lux and the RHL Group (respectively) were the rate of 15% (as opposed to 7%) to be applied up to 31 March 2024.
365p £63.5m (WATR.L)
The multinational provider of precision, minimally-invasive leak detection and remediation solutions for both potable and non-potable water, announces two transactions in its American Leak Detection (ALD) subsidiary: reacquisition of its franchise in Fresno, California for the purchase price of $2.9m in cash spread over two years; (2) sale of a new franchise for Albany and Saratoga, New York, for an upfront consideration of $0.1m. ALD expects to receive royalty income from sales starting in July after the completion of training.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.